| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.92e-12 | 12 | 28 | 5 | GO:0032396 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.15e-11 | 18 | 28 | 5 | GO:0032393 | |
| GeneOntologyMolecularFunction | IgM binding | 1.01e-09 | 11 | 28 | 4 | GO:0001791 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 2.46e-08 | 5 | 28 | 3 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 4.92e-08 | 6 | 28 | 3 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 8.61e-08 | 7 | 28 | 3 | GO:0023025 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.77e-07 | 36 | 28 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 1.37e-06 | 16 | 28 | 3 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 2.36e-06 | 19 | 28 | 3 | GO:0032394 | |
| GeneOntologyMolecularFunction | coreceptor activity | 2.98e-06 | 72 | 28 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | immune receptor activity | 3.06e-06 | 165 | 28 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.19e-05 | 32 | 28 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 1.57e-05 | 35 | 28 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 2.54e-05 | 41 | 28 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.21e-05 | 52 | 28 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | MHC protein binding | 7.24e-05 | 58 | 28 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.86e-04 | 102 | 28 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | complement binding | 9.16e-04 | 32 | 28 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.61e-03 | 167 | 28 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.33e-03 | 190 | 28 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.88e-03 | 430 | 28 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 2.97e-03 | 207 | 28 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 3.09e-03 | 210 | 28 | 3 | GO:0019903 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 3.18e-03 | 212 | 28 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.32e-03 | 739 | 28 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | phosphatase binding | 5.86e-03 | 264 | 28 | 3 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 6.78e-03 | 875 | 28 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | amide binding | 8.25e-03 | 299 | 28 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.26e-03 | 599 | 28 | 4 | GO:0050839 | |
| GeneOntologyMolecularFunction | peptide binding | 9.76e-03 | 318 | 28 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.00e-02 | 1356 | 28 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.25e-02 | 654 | 28 | 4 | GO:0008233 | |
| GeneOntologyBiologicalProcess | response to cytokine | CFH CASP3 ETV3 MCF2 LILRA2 FOXA2 LILRB5 LILRA5 PTGS2 LILRB2 LILRA4 | 1.15e-07 | 1083 | 29 | 11 | GO:0034097 |
| GeneOntologyBiologicalProcess | response to peptide | CFH CASP3 ETV3 MCF2 LILRA2 FOXA2 LILRB5 LILRA5 PTGS2 LILRB2 LILRA4 | 1.34e-07 | 1100 | 29 | 11 | GO:1901652 |
| GeneOntologyBiologicalProcess | B cell homeostasis | 5.87e-07 | 48 | 29 | 4 | GO:0001782 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 9.00e-07 | 14 | 29 | 3 | GO:1900454 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.36e-06 | 59 | 29 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 2.16e-06 | 153 | 29 | 5 | GO:0001776 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | CASP3 ILDR2 MCF2 LILRA2 PLG FOXA2 LILRB5 LILRA5 PTGS2 LILRB2 LILRA4 | 2.72e-06 | 1488 | 29 | 11 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 4.34e-06 | 23 | 29 | 3 | GO:1900452 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 4.63e-06 | 80 | 29 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | 5.69e-06 | 738 | 29 | 8 | GO:0032103 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 5.90e-06 | 85 | 29 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 7.06e-06 | 1316 | 29 | 10 | GO:0032101 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 7.99e-06 | 28 | 29 | 3 | GO:0043011 | |
| GeneOntologyBiologicalProcess | cell activation | CFH CASP3 ILDR2 SMARCC2 LILRA2 NKAP LILRB5 LILRA5 LILRB2 CFB | 9.21e-06 | 1356 | 29 | 10 | GO:0001775 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 1.08e-05 | 1077 | 29 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 1.15e-05 | 1085 | 29 | 9 | GO:0050776 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.22e-05 | 580 | 29 | 7 | GO:0022407 | |
| GeneOntologyBiologicalProcess | lymphocyte homeostasis | 1.31e-05 | 104 | 29 | 4 | GO:0002260 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | 1.35e-05 | 589 | 29 | 7 | GO:0031349 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.02e-05 | 116 | 29 | 4 | GO:0045670 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.47e-05 | 429 | 29 | 6 | GO:1902105 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | 3.16e-05 | 448 | 29 | 6 | GO:0048872 | |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 3.18e-05 | 44 | 29 | 3 | GO:0060292 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 3.37e-05 | 1242 | 29 | 9 | GO:0002684 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 3.57e-05 | 134 | 29 | 4 | GO:0045638 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell activation | 3.64e-05 | 46 | 29 | 3 | GO:0001773 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 4.97e-05 | 486 | 29 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | regulation of defense response | 5.34e-05 | 1006 | 29 | 8 | GO:0031347 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 5.68e-05 | 151 | 29 | 4 | GO:1902106 | |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 5.91e-05 | 54 | 29 | 3 | GO:0097028 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | 6.66e-05 | 756 | 29 | 7 | GO:0050865 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 6.76e-05 | 312 | 29 | 5 | GO:0002573 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 6.95e-05 | 159 | 29 | 4 | GO:1903707 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 7.47e-05 | 162 | 29 | 4 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 7.96e-05 | 323 | 29 | 5 | GO:0051924 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to osmotic stress | 8.53e-05 | 10 | 29 | 2 | GO:0008627 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 8.91e-05 | 540 | 29 | 6 | GO:1903706 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 8.94e-05 | 62 | 29 | 3 | GO:0035306 | |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 1.04e-04 | 11 | 29 | 2 | GO:0140105 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 1.07e-04 | 558 | 29 | 6 | GO:0030099 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 1.13e-04 | 67 | 29 | 3 | GO:1900271 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 1.17e-04 | 182 | 29 | 4 | GO:0002761 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.21e-04 | 353 | 29 | 5 | GO:0010721 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.56e-04 | 373 | 29 | 5 | GO:0007611 | |
| GeneOntologyBiologicalProcess | leukocyte activation | 1.69e-04 | 1186 | 29 | 8 | GO:0045321 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | 2.08e-04 | 631 | 29 | 6 | GO:0002683 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 2.37e-04 | 927 | 29 | 7 | GO:0030155 | |
| GeneOntologyBiologicalProcess | cognition | 2.80e-04 | 423 | 29 | 5 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 3.02e-04 | 233 | 29 | 4 | GO:0050806 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 3.07e-04 | 967 | 29 | 7 | GO:0071345 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 3.22e-04 | 19 | 29 | 2 | GO:0006957 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 3.60e-04 | 244 | 29 | 4 | GO:0019724 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 3.61e-04 | 447 | 29 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 3.69e-04 | 449 | 29 | 5 | GO:0002449 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 3.69e-04 | 449 | 29 | 5 | GO:0050867 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 3.94e-04 | 21 | 29 | 2 | GO:2000047 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | 4.00e-04 | 1010 | 29 | 7 | GO:0001817 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 4.04e-04 | 458 | 29 | 5 | GO:0050863 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 4.06e-04 | 252 | 29 | 4 | GO:0022408 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.20e-04 | 462 | 29 | 5 | GO:0002460 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 4.29e-04 | 464 | 29 | 5 | GO:0032496 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | 4.85e-04 | 1043 | 29 | 7 | GO:0048871 | |
| GeneOntologyBiologicalProcess | response to hexose | 4.91e-04 | 265 | 29 | 4 | GO:0009746 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 5.42e-04 | 272 | 29 | 4 | GO:0034284 | |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 5.54e-04 | 491 | 29 | 5 | GO:0002237 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 5.65e-04 | 493 | 29 | 5 | GO:0010959 | |
| GeneOntologyBiologicalProcess | cytokine production | 6.35e-04 | 1091 | 29 | 7 | GO:0001816 | |
| GeneOntologyBiologicalProcess | innate immune response | 6.39e-04 | 1092 | 29 | 7 | GO:0045087 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 6.49e-04 | 1095 | 29 | 7 | GO:0060284 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 6.53e-04 | 509 | 29 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 6.59e-04 | 122 | 29 | 3 | GO:0032755 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 6.71e-04 | 288 | 29 | 4 | GO:0045637 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 6.87e-04 | 789 | 29 | 6 | GO:0002521 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 7.13e-04 | 519 | 29 | 5 | GO:0045088 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 7.16e-04 | 293 | 29 | 4 | GO:0048167 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 7.58e-04 | 128 | 29 | 3 | GO:0035303 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | 7.92e-04 | 301 | 29 | 4 | GO:0009743 | |
| GeneOntologyBiologicalProcess | adaptive immune response | 9.41e-04 | 838 | 29 | 6 | GO:0002250 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 9.83e-04 | 845 | 29 | 6 | GO:0050778 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.07e-03 | 144 | 29 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 1.07e-03 | 144 | 29 | 3 | GO:0060291 | |
| GeneOntologyBiologicalProcess | immune effector process | 1.07e-03 | 859 | 29 | 6 | GO:0002252 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 1.14e-03 | 576 | 29 | 5 | GO:0002443 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | 1.15e-03 | 577 | 29 | 5 | GO:0019221 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 1.15e-03 | 577 | 29 | 5 | GO:0043269 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.18e-03 | 875 | 29 | 6 | GO:0045596 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 1.23e-03 | 586 | 29 | 5 | GO:0001819 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.23e-03 | 1220 | 29 | 7 | GO:0051093 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 1.25e-03 | 1223 | 29 | 7 | GO:0030097 | |
| GeneOntologyBiologicalProcess | behavior | 1.29e-03 | 891 | 29 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 1.44e-03 | 160 | 29 | 3 | GO:0051384 | |
| GeneOntologyBiologicalProcess | response to bacterium | 1.49e-03 | 916 | 29 | 6 | GO:0009617 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.50e-03 | 162 | 29 | 3 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.51e-03 | 614 | 29 | 5 | GO:0051249 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 3.74e-10 | 9 | 29 | 4 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 1.47e-09 | 12 | 29 | 4 | GO:0032997 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 6.23e-04 | 785 | 29 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | cell surface | 6.54e-04 | 1111 | 29 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 6.71e-04 | 519 | 29 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | blood microparticle | 1.03e-03 | 144 | 29 | 3 | GO:0072562 | |
| HumanPheno | Decreased circulating complement factor B concentration | 3.46e-05 | 5 | 10 | 2 | HP:0005416 | |
| MousePheno | decreased length of allograft survival | 2.82e-07 | 9 | 22 | 3 | MP:0004752 | |
| MousePheno | abnormal visual cortex morphology | 1.87e-06 | 16 | 22 | 3 | MP:0000805 | |
| MousePheno | abnormal occipital lobe morphology | 2.72e-06 | 18 | 22 | 3 | MP:0000804 | |
| MousePheno | abnormal dendritic cell differentiation | 3.79e-06 | 20 | 22 | 3 | MP:0008115 | |
| MousePheno | abnormal cell differentiation | 1.65e-05 | 795 | 22 | 8 | MP:0005076 | |
| MousePheno | abnormal pancreatic beta cell morphology | 2.84e-05 | 115 | 22 | 4 | MP:0005217 | |
| MousePheno | decreased pancreatic beta cell number | 3.47e-05 | 41 | 22 | 3 | MP:0003339 | |
| MousePheno | abnormal optic choroid morphology | 7.11e-05 | 52 | 22 | 3 | MP:0005098 | |
| MousePheno | abnormal pancreatic beta cell number | 7.97e-05 | 54 | 22 | 3 | MP:0020578 | |
| MousePheno | abnormal professional antigen presenting cell physiology | 8.87e-05 | 1004 | 22 | 8 | MP:0002452 | |
| MousePheno | abnormal circulating insulin level | 9.82e-05 | 505 | 22 | 6 | MP:0001560 | |
| MousePheno | increased B-1 B cell number | 1.04e-04 | 59 | 22 | 3 | MP:0004977 | |
| MousePheno | abnormal pancreatic beta cell differentiation | 1.06e-04 | 10 | 22 | 2 | MP:0009175 | |
| MousePheno | abnormal kidney thrombosis | 1.06e-04 | 10 | 22 | 2 | MP:0011507 | |
| MousePheno | abnormal response to transplant | 1.32e-04 | 64 | 22 | 3 | MP:0005671 | |
| MousePheno | abnormal T-helper 2 physiology | 1.52e-04 | 67 | 22 | 3 | MP:0005466 | |
| MousePheno | decreased neuron apoptosis | 1.96e-04 | 73 | 22 | 3 | MP:0003204 | |
| MousePheno | abnormal pancreatic islet morphology | 2.00e-04 | 190 | 22 | 4 | MP:0005215 | |
| MousePheno | abnormal endocrine pancreas morphology | 2.04e-04 | 191 | 22 | 4 | MP:0009165 | |
| MousePheno | increased B cell proliferation | 2.12e-04 | 75 | 22 | 3 | MP:0005154 | |
| MousePheno | abnormal pancreas morphology | 2.21e-04 | 367 | 22 | 5 | MP:0001944 | |
| MousePheno | abnormal adaptive immunity | 2.37e-04 | 1490 | 22 | 9 | MP:0002420 | |
| MousePheno | increased cell proliferation | 3.15e-04 | 396 | 22 | 5 | MP:0000351 | |
| MousePheno | abnormal endocrine pancreas development | 3.98e-04 | 19 | 22 | 2 | MP:0011932 | |
| MousePheno | decreased circulating glucagon level | 4.42e-04 | 20 | 22 | 2 | MP:0002696 | |
| MousePheno | abnormal innate immunity | 4.46e-04 | 667 | 22 | 6 | MP:0002419 | |
| MousePheno | abnormal mature B cell morphology | 5.17e-04 | 244 | 22 | 4 | MP:0008171 | |
| MousePheno | abnormal thrombosis | 5.88e-04 | 106 | 22 | 3 | MP:0005048 | |
| MousePheno | impaired muscle regeneration | 7.51e-04 | 26 | 22 | 2 | MP:0013160 | |
| MousePheno | impaired skeletal muscle regeneration | 7.51e-04 | 26 | 22 | 2 | MP:0013239 | |
| MousePheno | abnormal complement pathway | 7.51e-04 | 26 | 22 | 2 | MP:0002471 | |
| MousePheno | abnormal choroid vasculature morphology | 8.10e-04 | 27 | 22 | 2 | MP:0006237 | |
| MousePheno | premature death | 8.31e-04 | 1051 | 22 | 7 | MP:0002083 | |
| MousePheno | abnormal B-1 B cell number | 8.85e-04 | 122 | 22 | 3 | MP:0004976 | |
| MousePheno | increased circulating insulin level | 9.02e-04 | 283 | 22 | 4 | MP:0002079 | |
| MousePheno | decreased physiological sensitivity to xenobiotic | 9.02e-04 | 283 | 22 | 4 | MP:0008874 | |
| MousePheno | abnormal B-1 B cell morphology | 9.06e-04 | 123 | 22 | 3 | MP:0004940 | |
| MousePheno | abnormal leukocyte physiology | 9.87e-04 | 1425 | 22 | 8 | MP:0002442 | |
| MousePheno | abnormal pancreas physiology | 1.01e-03 | 292 | 22 | 4 | MP:0002693 | |
| MousePheno | reduced female fertility | 1.07e-03 | 296 | 22 | 4 | MP:0001923 | |
| MousePheno | abnormal immune cell physiology | 1.11e-03 | 1450 | 22 | 8 | MP:0001819 | |
| MousePheno | abnormal cell-mediated immunity | 1.18e-03 | 1463 | 22 | 8 | MP:0002421 | |
| MousePheno | abnormal pancreas development | 1.36e-03 | 35 | 22 | 2 | MP:0003934 | |
| MousePheno | abnormal dendritic cell morphology | 1.40e-03 | 143 | 22 | 3 | MP:0005461 | |
| MousePheno | increased circulating glucose level | 1.43e-03 | 553 | 22 | 5 | MP:0005559 | |
| MousePheno | decreased susceptibility to neuronal excitotoxicity | 1.52e-03 | 37 | 22 | 2 | MP:0008236 | |
| MousePheno | reduced fertility | 1.54e-03 | 844 | 22 | 6 | MP:0001921 | |
| MousePheno | abnormal B cell proliferation | 1.67e-03 | 152 | 22 | 3 | MP:0005153 | |
| MousePheno | abnormal circulating glucose level | 1.72e-03 | 1188 | 22 | 7 | MP:0000188 | |
| MousePheno | abnormal circulating glucagon level | 1.78e-03 | 40 | 22 | 2 | MP:0002695 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell physiology | 2.11e-03 | 165 | 22 | 3 | MP:0005463 | |
| MousePheno | abnormal B cell activation | 2.15e-03 | 166 | 22 | 3 | MP:0008217 | |
| MousePheno | increased mature B cell number | 2.22e-03 | 168 | 22 | 3 | MP:0008210 | |
| MousePheno | abnormal immune system development | 2.30e-03 | 616 | 22 | 5 | MP:0020981 | |
| MousePheno | abnormal B cell physiology | 2.30e-03 | 616 | 22 | 5 | MP:0002459 | |
| MousePheno | abnormal insulin secretion | 2.33e-03 | 171 | 22 | 3 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 2.53e-03 | 176 | 22 | 3 | MP:0014195 | |
| MousePheno | abnormal skeletal muscle regeneration | 2.55e-03 | 48 | 22 | 2 | MP:0013237 | |
| MousePheno | abnormal skeleton physiology | 2.58e-03 | 632 | 22 | 5 | MP:0001533 | |
| MousePheno | abnormal pancreas secretion | 2.83e-03 | 183 | 22 | 3 | MP:0002694 | |
| MousePheno | abnormal circulating hormone level | 2.88e-03 | 954 | 22 | 6 | MP:0005418 | |
| MousePheno | pulmonary fibrosis | 2.88e-03 | 51 | 22 | 2 | MP:0006050 | |
| MousePheno | abnormal inflammatory response | 3.02e-03 | 1310 | 22 | 7 | MP:0001845 | |
| MousePheno | abnormal bone ossification | 3.07e-03 | 395 | 22 | 4 | MP:0008271 | |
| Domain | IG | 2.21e-06 | 421 | 28 | 7 | SM00409 | |
| Domain | Ig_sub | 2.21e-06 | 421 | 28 | 7 | IPR003599 | |
| Domain | Ig_2 | 4.10e-06 | 73 | 28 | 4 | PF13895 | |
| Domain | Ig-like_dom | 7.14e-06 | 503 | 28 | 7 | IPR007110 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 3.24e-05 | 6 | 28 | 2 | IPR016332 | |
| Domain | Ig-like_fold | 6.33e-05 | 706 | 28 | 7 | IPR013783 | |
| Domain | IG_LIKE | 7.37e-05 | 491 | 28 | 6 | PS50835 | |
| Domain | ig | 1.75e-04 | 190 | 28 | 4 | PF00047 | |
| Domain | Immunoglobulin | 1.75e-04 | 190 | 28 | 4 | IPR013151 | |
| Domain | - | 3.78e-04 | 663 | 28 | 6 | 2.60.40.10 | |
| Domain | IGc2 | 3.95e-04 | 235 | 28 | 4 | SM00408 | |
| Domain | Ig_sub2 | 3.95e-04 | 235 | 28 | 4 | IPR003598 | |
| Domain | Sushi | 2.74e-03 | 52 | 28 | 2 | PF00084 | |
| Domain | CCP | 2.96e-03 | 54 | 28 | 2 | SM00032 | |
| Domain | SUSHI | 3.17e-03 | 56 | 28 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.29e-03 | 57 | 28 | 2 | IPR000436 | |
| Domain | - | 4.14e-03 | 218 | 28 | 3 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 5.54e-03 | 242 | 28 | 3 | IPR011991 | |
| Domain | TRYPSIN_SER | 8.00e-03 | 90 | 28 | 2 | IPR033116 | |
| Domain | TRYPSIN_HIS | 1.04e-02 | 103 | 28 | 2 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.10e-02 | 106 | 28 | 2 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.12e-02 | 107 | 28 | 2 | PS00134 | |
| Domain | Peptidase_S1A | 1.24e-02 | 113 | 28 | 2 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.28e-02 | 115 | 28 | 2 | PS50240 | |
| Domain | Tryp_SPc | 1.32e-02 | 117 | 28 | 2 | SM00020 | |
| Domain | Trypsin | 1.41e-02 | 121 | 28 | 2 | PF00089 | |
| Domain | Trypsin_dom | 1.41e-02 | 121 | 28 | 2 | IPR001254 | |
| Domain | Peptidase_S1_PA | 1.45e-02 | 123 | 28 | 2 | IPR009003 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 6.09e-07 | 190 | 24 | 6 | M8240 | |
| Pathway | WP_SPINAL_CORD_INJURY | 3.08e-05 | 108 | 24 | 4 | MM15954 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.26e-04 | 58 | 24 | 3 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.32e-04 | 59 | 24 | 3 | M48343 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.59e-04 | 995 | 24 | 8 | MM14661 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 1.70e-04 | 511 | 24 | 6 | MM15330 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 2.11e-04 | 69 | 24 | 3 | M16894 | |
| Pathway | WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING | 4.64e-04 | 218 | 24 | 4 | M42569 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 5.58e-04 | 96 | 24 | 3 | M39581 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 7.46e-04 | 106 | 24 | 3 | M42535 | |
| Pubmed | A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. | 5.29e-10 | 15 | 29 | 4 | 9144225 | |
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 5.21e-09 | 5 | 29 | 3 | 18787130 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 34242819 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 20976309 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 20881122 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 5.21e-09 | 5 | 29 | 3 | 15494528 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 19684158 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 37146940 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 5.21e-09 | 5 | 29 | 3 | 34120891 | |
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 5.21e-09 | 5 | 29 | 3 | 24302763 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 23927735 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 5.21e-09 | 5 | 29 | 3 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 5.21e-09 | 5 | 29 | 3 | 33653799 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 21087927 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 20398663 | ||
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 5.21e-09 | 5 | 29 | 3 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 5.21e-09 | 5 | 29 | 3 | 23152562 | |
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 5.21e-09 | 5 | 29 | 3 | 22948046 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 9054430 | ||
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 5.21e-09 | 5 | 29 | 3 | 10359805 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 27324131 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 10586026 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 5.21e-09 | 5 | 29 | 3 | 25075127 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 5.21e-09 | 5 | 29 | 3 | 22102155 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 5.21e-09 | 5 | 29 | 3 | 16011512 | |
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 23258232 | ||
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 5.21e-09 | 5 | 29 | 3 | 12403357 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 28664612 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 1.04e-08 | 6 | 29 | 3 | 12207326 | |
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 1.04e-08 | 6 | 29 | 3 | 27752542 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 9824165 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 38383888 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 39095838 | ||
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 1.04e-08 | 6 | 29 | 3 | 18988857 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 27402837 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 1.04e-08 | 6 | 29 | 3 | 21881600 | |
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 1.04e-08 | 6 | 29 | 3 | 12021780 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 15146181 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 1.04e-08 | 6 | 29 | 3 | 18768880 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 29482582 | ||
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 1.04e-08 | 6 | 29 | 3 | 37481670 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 31727773 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 25320232 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 30787106 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 21636572 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 24040397 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 24212998 | ||
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 30068593 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 36510132 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 19687229 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 17998301 | ||
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 1.82e-08 | 7 | 29 | 3 | 16917027 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 35321392 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 20844138 | ||
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 1.82e-08 | 7 | 29 | 3 | 17371981 | |
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 1.82e-08 | 7 | 29 | 3 | 21555536 | |
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 1.82e-08 | 7 | 29 | 3 | 19658091 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 1.82e-08 | 7 | 29 | 3 | 24278366 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 1.82e-08 | 7 | 29 | 3 | 18316626 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 27897222 | ||
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 2.91e-08 | 8 | 29 | 3 | 22660330 | |
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 9548455 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 21376641 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 2.91e-08 | 8 | 29 | 3 | 24449409 | |
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 2.91e-08 | 8 | 29 | 3 | 9538215 | |
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 2.91e-08 | 8 | 29 | 3 | 35210567 | |
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 4.36e-08 | 9 | 29 | 3 | 17420263 | |
| Pubmed | PIRs mediate innate myeloid cell memory to nonself MHC molecules. | 6.23e-08 | 10 | 29 | 3 | 32381589 | |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 6.23e-08 | 10 | 29 | 3 | 18802077 | |
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 8.56e-08 | 11 | 29 | 3 | 21364532 | |
| Pubmed | 8.56e-08 | 11 | 29 | 3 | 20145200 | ||
| Pubmed | 8.56e-08 | 11 | 29 | 3 | 24738827 | ||
| Pubmed | 8.56e-08 | 11 | 29 | 3 | 24052308 | ||
| Pubmed | 1.14e-07 | 12 | 29 | 3 | 22445338 | ||
| Pubmed | Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. | 1.14e-07 | 12 | 29 | 3 | 10611342 | |
| Pubmed | 1.48e-07 | 13 | 29 | 3 | 30452456 | ||
| Pubmed | Complement factor H is expressed in adipose tissue in association with insulin resistance. | 6.71e-07 | 2 | 29 | 2 | 19833879 | |
| Pubmed | [P38MAPK pathway regulates COX-2 and caspase-3 expression in a mouse model of Parkinson disease]. | 6.71e-07 | 2 | 29 | 2 | 19861252 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17413988 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 27241480 | ||
| Pubmed | Association of CFH and CFB gene polymorphisms with retinopathy in type 2 diabetic patients. | 6.71e-07 | 2 | 29 | 2 | 23864767 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12393390 | ||
| Pubmed | 1.04e-06 | 24 | 29 | 3 | 15723811 | ||
| Pubmed | Angiopoietin-like 2 is essential to aortic valve development in mice. | 1.34e-06 | 26 | 29 | 3 | 36414704 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23071278 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 19850343 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 12091909 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17420242 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23112567 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 19899988 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 34233521 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 21716255 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 19825847 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20007824 | ||
| Cytoband | 19q13.4 | 1.53e-09 | 79 | 29 | 5 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 8.61e-05 | 1192 | 29 | 6 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 1.04e-03 | 75 | 29 | 2 | chr1q31 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 1.96e-08 | 6 | 19 | 3 | 1181 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.20e-06 | 394 | 19 | 6 | 471 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 1.04e-05 | 5 | 19 | 2 | 1182 | |
| GeneFamily | Complement system|Sushi domain containing | 6.45e-04 | 36 | 19 | 2 | 492 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.61e-03 | 57 | 19 | 2 | 1179 | |
| Coexpression | SOUCEK_MYC_TARGETS | 1.17e-06 | 19 | 29 | 3 | MM1252 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 1.32e-06 | 74 | 29 | 4 | MM762 | |
| Coexpression | DESCARTES_FETAL_LUNG_MYELOID_CELLS | 1.42e-06 | 178 | 29 | 5 | M40244 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_DN | 3.44e-06 | 94 | 29 | 4 | MM787 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 4.76e-06 | 102 | 29 | 4 | MM1064 | |
| Coexpression | VILIMAS_NOTCH1_TARGETS_DN | 7.12e-06 | 34 | 29 | 3 | MM791 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 2.30e-05 | 50 | 29 | 3 | MM3805 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 4.97e-05 | 185 | 29 | 4 | M40148 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_R848_DC_DN | 5.98e-05 | 194 | 29 | 4 | M4692 | |
| Coexpression | GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN | 6.10e-05 | 195 | 29 | 4 | M9804 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN | 6.60e-05 | 199 | 29 | 4 | M8721 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 6.73e-05 | 200 | 29 | 4 | M9677 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 6.73e-05 | 200 | 29 | 4 | MM17082 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 6.73e-05 | 200 | 29 | 4 | M5913 | |
| Coexpression | HALLMARK_COMPLEMENT | 6.73e-05 | 200 | 29 | 4 | M5921 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_MICROGLIA | 6.75e-05 | 652 | 29 | 6 | M40157 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_DN | 7.49e-05 | 74 | 29 | 3 | M42506 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MYELOID_CELLS | 9.39e-05 | 218 | 29 | 4 | M40221 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | 1.15e-04 | 230 | 29 | 4 | M40210 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_MYELOID_CELLS | 1.30e-04 | 237 | 29 | 4 | M40264 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 1.40e-04 | 16 | 29 | 2 | M40964 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.67e-04 | 97 | 29 | 3 | MM1016 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 1.67e-04 | 97 | 29 | 3 | MM3789 | |
| Coexpression | DESCARTES_MAIN_FETAL_MYELOID_CELLS | 1.73e-04 | 98 | 29 | 3 | M40071 | |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 1.94e-04 | 102 | 29 | 3 | M39119 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 2.02e-04 | 266 | 29 | 4 | M1286 | |
| Coexpression | FOROUTAN_TGFB_EMT_DN | 2.30e-04 | 108 | 29 | 3 | M42502 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_MICROGLIA | 2.33e-04 | 516 | 29 | 5 | M40168 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 3.27e-04 | 302 | 29 | 4 | MM1046 | |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 3.62e-04 | 126 | 29 | 3 | M2309 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MYELOID_CELLS | 4.14e-04 | 132 | 29 | 3 | M40289 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_LEUKOCYTE_AGEING | 4.24e-04 | 133 | 29 | 3 | MM3715 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL | 4.26e-04 | 324 | 29 | 4 | M39160 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 4.68e-04 | 332 | 29 | 4 | MM3679 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP | 4.71e-04 | 29 | 29 | 2 | M41150 | |
| Coexpression | HALLMARK_COAGULATION | 4.72e-04 | 138 | 29 | 3 | M5946 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_MYELOID | 4.82e-04 | 139 | 29 | 3 | M39044 | |
| Coexpression | GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN | 5.90e-04 | 149 | 29 | 3 | M6708 | |
| Coexpression | GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 6.62e-04 | 155 | 29 | 3 | M8913 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | 7.53e-04 | 377 | 29 | 4 | M40997 | |
| Coexpression | HALLMARK_PANCREAS_BETA_CELLS | 8.98e-04 | 40 | 29 | 2 | M5957 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 9.56e-04 | 176 | 29 | 3 | MM1048 | |
| Coexpression | ATF2_UP.V1_DN | 1.10e-03 | 185 | 29 | 3 | M2684 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ALVEOLAR_MACROPHAGE_AGEING | 1.12e-03 | 186 | 29 | 3 | MM3762 | |
| Coexpression | ROVERSI_GLIOMA_LOH_REGIONS | 1.14e-03 | 45 | 29 | 2 | M6712 | |
| Coexpression | PGF_UP.V1_UP | 1.19e-03 | 190 | 29 | 3 | M2674 | |
| Coexpression | GSE45365_BCELL_VS_CD8_TCELL_DN | 1.21e-03 | 191 | 29 | 3 | M9992 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN | 1.23e-03 | 192 | 29 | 3 | M4703 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP | 1.25e-03 | 193 | 29 | 3 | M13479 | |
| Coexpression | GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP | 1.27e-03 | 194 | 29 | 3 | M4152 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 1.28e-03 | 195 | 29 | 3 | M8151 | |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP | 1.30e-03 | 196 | 29 | 3 | M5873 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 1.30e-03 | 196 | 29 | 3 | MM3746 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_R848_DC_DN | 1.32e-03 | 197 | 29 | 3 | M4694 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP | 1.32e-03 | 197 | 29 | 3 | M5867 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP | 1.34e-03 | 198 | 29 | 3 | M8158 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN | 1.34e-03 | 198 | 29 | 3 | M8723 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 1.34e-03 | 198 | 29 | 3 | M6114 | |
| Coexpression | HALMOS_CEBPA_TARGETS_UP | 1.35e-03 | 49 | 29 | 2 | M11064 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN | 1.36e-03 | 199 | 29 | 3 | M9061 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 1.36e-03 | 199 | 29 | 3 | M8435 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN | 1.36e-03 | 199 | 29 | 3 | M5242 | |
| Coexpression | GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M8540 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN | 1.38e-03 | 200 | 29 | 3 | M8106 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN | 1.38e-03 | 200 | 29 | 3 | M6419 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN | 1.38e-03 | 200 | 29 | 3 | M4638 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DN | 1.38e-03 | 200 | 29 | 3 | M4938 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP | 1.38e-03 | 200 | 29 | 3 | M4528 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN | 1.38e-03 | 200 | 29 | 3 | M8735 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_UP | 1.38e-03 | 200 | 29 | 3 | M5953 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP | 1.38e-03 | 200 | 29 | 3 | M3894 | |
| Coexpression | GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP | 1.38e-03 | 200 | 29 | 3 | M4305 | |
| Coexpression | TSUNODA_CISPLATIN_RESISTANCE_DN | 1.40e-03 | 50 | 29 | 2 | M5014 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_200 | 4.67e-05 | 8 | 28 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_200 | |
| CoexpressionAtlas | spleen | 5.17e-05 | 315 | 28 | 5 | spleen | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 1.05e-04 | 366 | 28 | 5 | GSM854255_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2 | 1.65e-04 | 403 | 28 | 5 | GSM605834_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 1.72e-04 | 407 | 28 | 5 | GSM854287_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3 | 1.80e-04 | 411 | 28 | 5 | GSM538274_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1 | 1.87e-04 | 414 | 28 | 5 | GSM538262_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 1.95e-04 | 418 | 28 | 5 | GSM605836_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 1.97e-04 | 419 | 28 | 5 | GSM854285_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.79e-04 | 97 | 28 | 3 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.91e-04 | 283 | 28 | 4 | gudmap_developingGonad_P2_ovary_1000_k2 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.21e-04 | 28 | 28 | 2 | gudmap_kidney_adult_RenalCortexMixed_Std_k3_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#3_top-relative-expression-ranked_500 | 6.21e-04 | 28 | 28 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k3_500 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-08 | 143 | 29 | 5 | 7adc34d8ad11e57950a5a258ae9bf8f52259385a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-07 | 193 | 29 | 5 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-07 | 193 | 29 | 5 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-07 | 193 | 29 | 5 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.55e-07 | 194 | 29 | 5 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 1.55e-07 | 194 | 29 | 5 | 3c4ac5f91b10802990b84db3406f5e71f8ee8b74 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-07 | 195 | 29 | 5 | 935461e849ca4d17627341b3ae5124d497793a91 | |
| ToppCell | distal-1-Hematologic-Nonclassical_Monocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-07 | 195 | 29 | 5 | e1a8171d1af53c2bbda758170c5053d3a3bb6ddd | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-07 | 195 | 29 | 5 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.63e-07 | 196 | 29 | 5 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-07 | 197 | 29 | 5 | 8d6551e118cfe308088487c6d5171d986f90fb2f | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-07 | 198 | 29 | 5 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-07 | 198 | 29 | 5 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.71e-07 | 198 | 29 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-07 | 198 | 29 | 5 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.71e-07 | 198 | 29 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-07 | 199 | 29 | 5 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-07 | 199 | 29 | 5 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-07 | 199 | 29 | 5 | 36662a76211162b1bf2d58dc819cae339f715c5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-06 | 160 | 29 | 4 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-06 | 163 | 29 | 4 | 3087224d3f16f5d3aecc3e1e4366220231afe31f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.86e-06 | 165 | 29 | 4 | c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 4.14e-06 | 168 | 29 | 4 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-06 | 170 | 29 | 4 | 1c3c03821c90d41de92fef3278f71093a7fd709c | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 4.44e-06 | 171 | 29 | 4 | 098a7fd387357c0d4e1a6169af4d24ef95b30018 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 4.76e-06 | 174 | 29 | 4 | 05d54a36772f096047521e16a89cc42ae48d2a1d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 180 | 29 | 4 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-06 | 181 | 29 | 4 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-06 | 181 | 29 | 4 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 5.94e-06 | 184 | 29 | 4 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.94e-06 | 184 | 29 | 4 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.06e-06 | 185 | 29 | 4 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-06 | 185 | 29 | 4 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.33e-06 | 187 | 29 | 4 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-06 | 189 | 29 | 4 | 984b5f21e84dd8273d8437ac2a5a9de4e9484b9a | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.74e-06 | 190 | 29 | 4 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.88e-06 | 191 | 29 | 4 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.02e-06 | 192 | 29 | 4 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.02e-06 | 192 | 29 | 4 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.17e-06 | 193 | 29 | 4 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Monocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.17e-06 | 193 | 29 | 4 | e67e960a5312ed73c5169795cb282e431866b9c1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-06 | 193 | 29 | 4 | 891c0d4119a1c090b8230d00f9f69997850cab8c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.17e-06 | 193 | 29 | 4 | ddbd8944661ac3b0b5fe63471bdc24ba05598017 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.17e-06 | 193 | 29 | 4 | d845beb0915a5b4bbd1e8f9b8d9322527a822849 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-06 | 194 | 29 | 4 | 16c6fcbd36d473b883fb5361caca86eb134767ab | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.32e-06 | 194 | 29 | 4 | f1cabb198ab32deaf299899c5e8f42d861b8c574 | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.32e-06 | 194 | 29 | 4 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.32e-06 | 194 | 29 | 4 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.32e-06 | 194 | 29 | 4 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-06 | 194 | 29 | 4 | de9c7c602d886d0cd8bbd1d7e7744f84df951238 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.32e-06 | 194 | 29 | 4 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-06 | 194 | 29 | 4 | 49441ca0a8fa34cb847fecbb4b809dd01d879ebb | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.32e-06 | 194 | 29 | 4 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | (2)_Mono_macro|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.32e-06 | 194 | 29 | 4 | 7c05525614ee8cdfcbf22cce9146a8e73af7d14e | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.32e-06 | 194 | 29 | 4 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.32e-06 | 194 | 29 | 4 | 85c5d07189eb7bb413f708a3ca40de08af3cb106 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.32e-06 | 194 | 29 | 4 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.47e-06 | 195 | 29 | 4 | 6c354c38ee2965d37152ffdc86ba929ba2049c6a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.47e-06 | 195 | 29 | 4 | 403d874198a7bde626b0d0b4efad8dbb34060761 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.47e-06 | 195 | 29 | 4 | 6f417bb464b8ae6a50bbab5db5a6d5760c02122f | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-06 | 195 | 29 | 4 | d1ec768573929c717bb6b20ad5f26c4549cfcaed | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 195 | 29 | 4 | d8d2467196d7b2ce0c2cf6782e03e6db141ed3bf | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 7.47e-06 | 195 | 29 | 4 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | 390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-06 | 195 | 29 | 4 | 6f09bfd6394c10c90c23d130a18941bf490e1a8f | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-06 | 195 | 29 | 4 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.47e-06 | 195 | 29 | 4 | b5ee368c97113432fc8fe742654cd538558f327c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.47e-06 | 195 | 29 | 4 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 195 | 29 | 4 | 68b579258caf023570c3922269e831e27d847934 | |
| ToppCell | severe-Classical_Monocyte|World / disease stage, cell group and cell class | 7.47e-06 | 195 | 29 | 4 | cf638aac4d57ae0774008920a1a5e9dfd8c73885 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.62e-06 | 196 | 29 | 4 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.62e-06 | 196 | 29 | 4 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | tumor_Lung-Myeloid_cells-Monocytes|tumor_Lung / Location, Cell class and cell subclass | 7.62e-06 | 196 | 29 | 4 | 4a00c416688ae06ed2aef19626a485f646925d67 | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.62e-06 | 196 | 29 | 4 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | distal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.62e-06 | 196 | 29 | 4 | c1f3334bc09f5d0cfb9d998a3a64f0700426a357 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 7.62e-06 | 196 | 29 | 4 | 7fe97109a5a06b35fc081a85f341ea78da131323 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.62e-06 | 196 | 29 | 4 | 008e7593ab26988b957673f863bdd017516281ae | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.62e-06 | 196 | 29 | 4 | 23e22dfb9f9aec17b83574295f889e75f46ded50 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.62e-06 | 196 | 29 | 4 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.62e-06 | 196 | 29 | 4 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.62e-06 | 196 | 29 | 4 | a1b21f4667c05e837a1229cc5934db805ad562c5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.62e-06 | 196 | 29 | 4 | 555c9e443fe3b9893cb320b78d84002e1f8c1701 | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-06 | 197 | 29 | 4 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | severe-Classical_Monocyte|severe / disease stage, cell group and cell class | 7.77e-06 | 197 | 29 | 4 | 1263f141fd03a9294127ab5572893f7ae8b49230 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-06 | 197 | 29 | 4 | f431f11196dc4332933b5d71c7c7408d54c2dedc | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-06 | 197 | 29 | 4 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 7.77e-06 | 197 | 29 | 4 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-06 | 197 | 29 | 4 | c6e977adb1248957d31300312310e08238b64236 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-06 | 197 | 29 | 4 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | normal_Lung-Myeloid_cells-Monocytes|normal_Lung / Location, Cell class and cell subclass | 7.77e-06 | 197 | 29 | 4 | f32f1a0455c2cfdd5f187b10f6a3fd4877874c09 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-06 | 197 | 29 | 4 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.77e-06 | 197 | 29 | 4 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 7.77e-06 | 197 | 29 | 4 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | URO-Myeloid-CD16_Mono|URO / Disease, Lineage and Cell Type | 7.77e-06 | 197 | 29 | 4 | 0201ba77419487e75edd5ea07ad7e5cbe87757d4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 197 | 29 | 4 | c34d0d11c5c6154988b41e00aea169090cb09785 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.77e-06 | 197 | 29 | 4 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.77e-06 | 197 | 29 | 4 | a1d42d0177630e08f36a96a6272f796244c1a319 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-06 | 197 | 29 | 4 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.77e-06 | 197 | 29 | 4 | bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.93e-06 | 198 | 29 | 4 | 03ba8bf87bb2b7aaa560ccca95636cb1d11d5ead | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 7.93e-06 | 198 | 29 | 4 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| Computational | Genes in the cancer module 46. | 6.34e-04 | 394 | 20 | 5 | MODULE_46 | |
| Computational | Neighborhood of HCK | 6.63e-04 | 94 | 20 | 3 | GNF2_HCK | |
| Computational | Immune response. | 6.64e-04 | 398 | 20 | 5 | MODULE_75 | |
| Computational | Genes in the cancer module 58. | 6.76e-04 | 21 | 20 | 2 | MODULE_58 | |
| Computational | Complement. | 8.13e-04 | 23 | 20 | 2 | MODULE_130 | |
| Computational | Neighborhood of PAX7 | 1.30e-03 | 266 | 20 | 4 | MORF_PAX7 | |
| Drug | IL-T | 6.43e-07 | 56 | 28 | 4 | CID000150551 | |
| Drug | 3,3',4,4',5,5'-hexahydroxystilbene | 8.74e-06 | 4 | 28 | 2 | ctd:C514772 | |
| Drug | ponasterone A | 8.74e-06 | 4 | 28 | 2 | ctd:C008999 | |
| Drug | amarogentin | 8.74e-06 | 4 | 28 | 2 | ctd:C102609 | |
| Drug | perfluoro-n-nonanoic acid | 1.11e-05 | 114 | 28 | 4 | ctd:C101816 | |
| Drug | Humic Substances | 1.16e-05 | 36 | 28 | 3 | ctd:D006812 | |
| Drug | L-161982 | 1.46e-05 | 5 | 28 | 2 | ctd:C508711 | |
| Drug | Scutellaria baicalensis extract | 3.05e-05 | 7 | 28 | 2 | ctd:C499814 | |
| Drug | pyrimethanil | 3.05e-05 | 7 | 28 | 2 | ctd:C108337 | |
| Drug | 19-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide | 3.05e-05 | 7 | 28 | 2 | ctd:C547088 | |
| Drug | 7,8-diacetoxy-4-methylthiocoumarin | 4.07e-05 | 8 | 28 | 2 | ctd:C540361 | |
| Drug | chan su | 4.07e-05 | 8 | 28 | 2 | ctd:C095591 | |
| Drug | ibandronic acid | 4.07e-05 | 8 | 28 | 2 | ctd:C073007 | |
| Drug | dapoxetine | 4.07e-05 | 8 | 28 | 2 | ctd:C080598 | |
| Drug | dexamethasone 21-phosphate | 4.07e-05 | 8 | 28 | 2 | ctd:C004180 | |
| Drug | Poly(amidoamine) | 4.19e-05 | 55 | 28 | 3 | ctd:C531249 | |
| Drug | tamarixetin | 5.22e-05 | 9 | 28 | 2 | ctd:C508967 | |
| Drug | neohesperidin dihydrochalcone | 5.22e-05 | 9 | 28 | 2 | ctd:C013613 | |
| Drug | Eriocalyxin B | 6.52e-05 | 10 | 28 | 2 | CID000367620 | |
| Drug | JZL 184 | 6.52e-05 | 10 | 28 | 2 | ctd:C534333 | |
| Drug | Tranexamic Acid | 6.52e-05 | 10 | 28 | 2 | ctd:D014148 | |
| Drug | Benzophenanthridines | 7.57e-05 | 67 | 28 | 3 | ctd:D053119 | |
| Drug | sodium sulfite | 7.97e-05 | 11 | 28 | 2 | ctd:C025026 | |
| Drug | AC1L1BKL | 7.97e-05 | 11 | 28 | 2 | CID000001479 | |
| Drug | L-161982 | 7.97e-05 | 11 | 28 | 2 | CID005312129 | |
| Drug | calycopterin | 7.97e-05 | 11 | 28 | 2 | ctd:C533734 | |
| Drug | jaceosidin | 7.97e-05 | 11 | 28 | 2 | CID005379096 | |
| Drug | prostaglandin E2 glyceryl ester | 7.97e-05 | 11 | 28 | 2 | ctd:C518978 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 8.22e-05 | 190 | 28 | 4 | 2700_UP | |
| Drug | 9,10-anthraquinone | 9.55e-05 | 12 | 28 | 2 | ctd:C042834 | |
| Drug | ergolide | 9.55e-05 | 12 | 28 | 2 | CID000185786 | |
| Drug | beta-ionone | 9.55e-05 | 12 | 28 | 2 | ctd:C008157 | |
| Drug | 2-aminodiphenyl | 9.55e-05 | 12 | 28 | 2 | ctd:C014970 | |
| Drug | MC1568 | 9.55e-05 | 12 | 28 | 2 | ctd:C577554 | |
| Drug | 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one | 9.55e-05 | 12 | 28 | 2 | ctd:C000603962 | |
| Drug | Go 6976 | 1.06e-04 | 75 | 28 | 3 | ctd:C081021 | |
| Drug | beta-Tocopherol | 1.13e-04 | 13 | 28 | 2 | ctd:D024503 | |
| Drug | demethylnobiletin | 1.13e-04 | 13 | 28 | 2 | CID000358832 | |
| Drug | epostane | 1.13e-04 | 13 | 28 | 2 | ctd:C046855 | |
| Drug | obacunone glucoside | 1.13e-04 | 13 | 28 | 2 | ctd:C411188 | |
| Drug | 12-MTA | 1.13e-04 | 13 | 28 | 2 | CID000021672 | |
| Drug | triethylene glycol dimethacrylate | 1.13e-04 | 13 | 28 | 2 | ctd:C020946 | |
| Drug | MK 2206 | 1.13e-04 | 13 | 28 | 2 | ctd:C548887 | |
| Drug | Dehydroascorbic Acid | 1.13e-04 | 13 | 28 | 2 | ctd:D003683 | |
| Drug | Amiloride | 1.19e-04 | 78 | 28 | 3 | ctd:D000584 | |
| Drug | Hydrolyzable Tannins | 1.32e-04 | 14 | 28 | 2 | ctd:D047348 | |
| Drug | ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate | 1.32e-04 | 14 | 28 | 2 | ctd:C530049 | |
| Drug | 4-iodo-2,5-dimethoxyphenylisopropylamine | 1.32e-04 | 14 | 28 | 2 | ctd:C015952 | |
| Drug | obacunone | 1.32e-04 | 14 | 28 | 2 | ctd:C067207 | |
| Drug | 1zz2 | 1.38e-04 | 82 | 28 | 3 | CID005287728 | |
| Drug | 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol | 1.52e-04 | 15 | 28 | 2 | ctd:C435044 | |
| Drug | ioversol | 1.52e-04 | 15 | 28 | 2 | CID000003741 | |
| Drug | Bisphenol A-Glycidyl Methacrylate | 1.52e-04 | 15 | 28 | 2 | ctd:D017438 | |
| Drug | amentoflavone | 1.52e-04 | 15 | 28 | 2 | ctd:C011164 | |
| Drug | Misoprostol | 1.73e-04 | 16 | 28 | 2 | ctd:D016595 | |
| Drug | alpha-viniferin | 1.73e-04 | 16 | 28 | 2 | ctd:C064176 | |
| Drug | wedelolactone | 1.73e-04 | 16 | 28 | 2 | ctd:C051122 | |
| Drug | Diosmin | 1.73e-04 | 16 | 28 | 2 | ctd:D004145 | |
| Drug | dictyolene | 1.73e-04 | 16 | 28 | 2 | CID000001477 | |
| Drug | 7-nitroindazole | 1.73e-04 | 16 | 28 | 2 | ctd:C080122 | |
| Drug | Buserelin | 1.73e-04 | 16 | 28 | 2 | ctd:D002064 | |
| Drug | primaquine | 1.76e-04 | 89 | 28 | 3 | CID000004908 | |
| Drug | Polyethyleneimine | 1.82e-04 | 90 | 28 | 3 | ctd:D011094 | |
| Drug | kolaviron | 1.96e-04 | 17 | 28 | 2 | ctd:C045492 | |
| Drug | TEMPO | 1.96e-04 | 17 | 28 | 2 | ctd:C003959 | |
| Drug | 7,8-diacetoxy-4-methylcoumarin | 1.96e-04 | 17 | 28 | 2 | ctd:C114369 | |
| Drug | cyprodinil | 1.96e-04 | 17 | 28 | 2 | ctd:C108338 | |
| Drug | Bupivacaine | 1.96e-04 | 17 | 28 | 2 | ctd:D002045 | |
| Drug | arachidonyltrifluoromethane | 2.20e-04 | 18 | 28 | 2 | ctd:C081565 | |
| Drug | tangeretin | 2.20e-04 | 18 | 28 | 2 | ctd:C059006 | |
| Drug | butaprost | 2.20e-04 | 18 | 28 | 2 | ctd:C048491 | |
| Drug | 5,7-dimethoxyflavone | 2.20e-04 | 18 | 28 | 2 | ctd:C060298 | |
| Drug | rubimaillin | 2.20e-04 | 18 | 28 | 2 | ctd:C046245 | |
| Drug | Olive Oil | 2.20e-04 | 96 | 28 | 3 | ctd:D000069463 | |
| Drug | mangostin | 2.46e-04 | 19 | 28 | 2 | ctd:C021053 | |
| Drug | CD 86022 | 2.46e-04 | 19 | 28 | 2 | CID000122617 | |
| Drug | S-methylisothiopseudouronium | 2.46e-04 | 19 | 28 | 2 | ctd:C027744 | |
| Drug | Isatin | 2.46e-04 | 19 | 28 | 2 | ctd:D007510 | |
| Drug | paeonol | 2.46e-04 | 19 | 28 | 2 | ctd:C013638 | |
| Drug | GP-49 | 2.46e-04 | 19 | 28 | 2 | CID003001259 | |
| Drug | 2bxt | 2.46e-04 | 19 | 28 | 2 | CID011363491 | |
| Drug | 9-methoxycamptothecin | 2.46e-04 | 19 | 28 | 2 | ctd:C025724 | |
| Drug | zingerone | 2.46e-04 | 19 | 28 | 2 | ctd:C013738 | |
| Drug | tylophorine | 2.46e-04 | 19 | 28 | 2 | ctd:C004218 | |
| Drug | polyethylene glycol PEG 4000 | 2.46e-04 | 19 | 28 | 2 | CID000448032 | |
| Drug | vinorelbine | 2.73e-04 | 20 | 28 | 2 | ctd:C030852 | |
| Drug | cholest-5-en-3 beta,7 alpha-diol | 2.73e-04 | 20 | 28 | 2 | ctd:C011724 | |
| Drug | fucoxanthin | 2.73e-04 | 20 | 28 | 2 | ctd:C025164 | |
| Drug | Zwittergent 3-16 | 2.73e-04 | 20 | 28 | 2 | CID000092176 | |
| Drug | Viper Venoms | 2.73e-04 | 20 | 28 | 2 | ctd:D014757 | |
| Drug | Platinum | 2.73e-04 | 20 | 28 | 2 | ctd:D010984 | |
| Drug | Danazol | 2.73e-04 | 20 | 28 | 2 | ctd:D003613 | |
| Drug | nectandrin-B | 2.73e-04 | 20 | 28 | 2 | ctd:C524653 | |
| Drug | sodium bisulfite | 2.73e-04 | 20 | 28 | 2 | ctd:C009279 | |
| Drug | AC1O5S1P | 3.02e-04 | 21 | 28 | 2 | CID006439617 | |
| Drug | gastrodin | 3.02e-04 | 21 | 28 | 2 | ctd:C045345 | |
| Drug | carfilzomib | 3.02e-04 | 21 | 28 | 2 | ctd:C524865 | |
| Drug | Etodolac | 3.32e-04 | 22 | 28 | 2 | ctd:D017308 | |
| Drug | brucine | 3.32e-04 | 22 | 28 | 2 | ctd:C083806 | |
| Drug | 2,3-dibromopropyl-2,4,6-tribromophenyl ether | 3.32e-04 | 22 | 28 | 2 | ctd:C547124 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 1.26e-07 | 11 | 28 | 3 | EFO_0008209 | |
| Disease | cysteine and glycine-rich protein 2 measurement | 2.60e-06 | 3 | 28 | 2 | EFO_0802444 | |
| Disease | complement C3D fragment measurement | 2.60e-06 | 3 | 28 | 2 | EFO_0020277 | |
| Disease | receptor tyrosine-protein kinase erbb-3 measurement | 5.20e-06 | 4 | 28 | 2 | EFO_0020701 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily A member 5 in blood serum | 5.20e-06 | 4 | 28 | 2 | OBA_2042197 | |
| Disease | sorting nexin-7 measurement | 5.20e-06 | 4 | 28 | 2 | EFO_0803094 | |
| Disease | creatine kinase m-type:creatine kinase b-type heterodimer measurement | 8.67e-06 | 5 | 28 | 2 | EFO_0020292 | |
| Disease | interleukin-10 receptor subunit beta measurement | 8.67e-06 | 5 | 28 | 2 | EFO_0020489 | |
| Disease | thymidine kinase, cytosolic measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0020773 | |
| Disease | NKG2-E type II integral membrane protein measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0801842 | |
| Disease | aurora kinase B measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0020169 | |
| Disease | transcription factor AP-1 measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0021909 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0021905 | |
| Disease | erythrocyte aggregation | 1.30e-05 | 6 | 28 | 2 | EFO_0803375 | |
| Disease | DNA-binding protein SATB2 measurement | 1.30e-05 | 6 | 28 | 2 | EFO_0802484 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 4 measurement | 1.82e-05 | 7 | 28 | 2 | EFO_0801765 | |
| Disease | mast/stem cell growth factor receptor kit measurement | 1.82e-05 | 7 | 28 | 2 | EFO_0020554 | |
| Disease | Glomerulonephritis, Membranoproliferative | 1.82e-05 | 7 | 28 | 2 | C0017662 | |
| Disease | creatine kinase measurement | 2.40e-05 | 59 | 28 | 3 | EFO_0004534 | |
| Disease | anterior uveitis (is_implicated_in) | 2.42e-05 | 8 | 28 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | PH and SEC7 domain-containing protein 1 measurement | 2.42e-05 | 8 | 28 | 2 | EFO_0803302 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 2.42e-05 | 8 | 28 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 3.11e-05 | 9 | 28 | 2 | EFO_0803293 | |
| Disease | C3 glomerulopathy | 3.11e-05 | 9 | 28 | 2 | C4087273 | |
| Disease | Atypical hemolytic-uremic syndrome | 3.11e-05 | 9 | 28 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 3.11e-05 | 9 | 28 | 2 | cv:C0019061 | |
| Disease | complement factor B measurement | 3.11e-05 | 9 | 28 | 2 | EFO_0008096 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 3.11e-05 | 9 | 28 | 2 | EFO_0801766 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 3.11e-05 | 9 | 28 | 2 | EFO_0010613 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 3.89e-05 | 10 | 28 | 2 | C2931788 | |
| Disease | interleukin-37 measurement | 3.89e-05 | 10 | 28 | 2 | EFO_0020506 | |
| Disease | wet macular degeneration | 7.85e-05 | 14 | 28 | 2 | EFO_0004683 | |
| Disease | sarcoidosis (is_implicated_in) | 1.03e-04 | 16 | 28 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.17e-04 | 17 | 28 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Age-related macular degeneration | 1.32e-04 | 18 | 28 | 2 | cv:C0242383 | |
| Disease | Streptozotocin Diabetes | 1.46e-04 | 108 | 28 | 3 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.46e-04 | 108 | 28 | 3 | C0011853 | |
| Disease | Alloxan Diabetes | 1.46e-04 | 108 | 28 | 3 | C0002152 | |
| Disease | COVID-19 (is_implicated_in) | 1.80e-04 | 21 | 28 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.80e-04 | 21 | 28 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | glycoprotein measurement | 1.95e-04 | 119 | 28 | 3 | EFO_0004555 | |
| Disease | atrophic macular degeneration | 2.57e-04 | 25 | 28 | 2 | EFO_1001492 | |
| Disease | Edema | 2.78e-04 | 26 | 28 | 2 | C0013604 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 2.78e-04 | 26 | 28 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | L lactate dehydrogenase measurement | 2.78e-04 | 26 | 28 | 2 | EFO_0004808 | |
| Disease | Anasarca | 2.78e-04 | 26 | 28 | 2 | C0151603 | |
| Disease | macular degeneration (is_implicated_in) | 3.00e-04 | 27 | 28 | 2 | DOID:4448 (is_implicated_in) | |
| Disease | retinal degeneration (biomarker_via_orthology) | 3.23e-04 | 28 | 28 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Parkinsonism (implicated_via_orthology) | 3.47e-04 | 29 | 28 | 2 | DOID:0080855 (implicated_via_orthology) | |
| Disease | Age related macular degeneration | 3.72e-04 | 30 | 28 | 2 | C0242383 | |
| Disease | Complement deficiency disease | 4.50e-04 | 33 | 28 | 2 | C0272242 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.44e-04 | 169 | 28 | 3 | DOID:3908 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 5.63e-04 | 171 | 28 | 3 | DOID:9352 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPSPQSYDSWDYSEL | 286 | F5H4B4 | |
| YSSAYPLHDGQYWKP | 246 | Q75V66 | |
| GYQFPDWAYKTESSP | 16 | P41162 | |
| WAQLSSPPYYYGDSV | 701 | P08603 | |
| YDSPSCKGTAYWYPP | 1456 | Q5TGY3 | |
| AYSTAPGYYSWRNSK | 196 | P42574 | |
| SSWGYPYEAPPSYEQ | 406 | Q8N5I2 | |
| YAYDSNSPYVWSLPS | 196 | Q8N149 | |
| NGEYWPRSPYYNVSD | 111 | P00751 | |
| YGYENNTPYVWSEPS | 196 | P59901 | |
| CYYYSPAGWSEPSDP | 116 | A6NI73 | |
| CYGYDLNSPYVWSSP | 196 | Q8N423 | |
| DSPPTYNADYGYKSW | 111 | P35354 | |
| YRCYYETPAGWSEPS | 96 | O75023 | |
| SWYKVFDPSCGLPYY | 51 | O60828 | |
| EPAEWSSNYFYPTYD | 891 | P10911 | |
| YGSYSRPYGSDKPWP | 101 | Q8N5F7 | |
| EPSDWSSYYAEPEGY | 11 | Q9Y261 | |
| YYPPEVSISGYDNNW | 241 | P15151 | |
| DYASYWTSSPKPSSY | 381 | Q93075 | |
| RAATPFSDSWYYPSY | 281 | Q96BY9 | |
| AKEGPSYPSYDWFQT | 161 | Q7L1T6 | |
| GPWCYTTDPEKRYDY | 161 | P00747 | |
| GYYPDSYDTWIPASE | 206 | Q8TAQ2 | |
| RSASYYAWSPPGTYK | 561 | Q71H61 | |
| PPKGYSGQDFDWADY | 371 | Q5VUG0 | |
| DTSDPSYGLFWYKQP | 46 | A0A0A6YYC5 | |
| IYKDSYGASSPWCDY | 1361 | P35573 | |
| SNDPYPYPRYTDDWF | 191 | P16519 |